Cell Isolation Market

Report Code BT 2757
Published in Jul, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cell Isolation Market / Cell Separation Market Size, Share & Trends by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029

Overview

The cell isolation market is expected to generate a revenue of USD 8.4 billion by 2029, with a revenue of USD 4.6 billion in 2024 to register a CAGR of 12.9%. The growth of the market can be attributed to the growing focus on technology advancement along with the development of new products that are more economical, technologically advanced, and easy to use. In the past 3 years, key players have launched various cell isolation products such as the next-generation platform of Gibco CTS Detachable Dynabeads (Thermo Fisher Scientific Inc.), BD FACSDiscover S8 cell sorter (BD), CultureOne Maxi (ALFA LAVAL), among others. The launch of these systems is expected to increase their adoption for cell isolation. Furthermore, research activities and funding availability by the government for cell-based research have increased as newer and better treatments for chronic diseases including autoimmune, neurological, and cardiovascular disorders become more necessary. This funding for cell-based research is likely to boost the growth of the market. In addition, various other factors including a surge in cases of cancer and infectious diseases, a growing focus on personalized medicine and next-generation therapeutics are further likely to boost the market growth.

Attractive Opportunities in the Cell Isolation Market / Cell Separation Market

ASIA PACIFIC:

The growth of the Asia Pacific cell isolation market is primarily due to increasing findings for cell-based research and growing expansion of key players in the region.

Growth in this market is primarily driven by the increasing prevalence of cancer and infectious diseases, growing technological advancements, and rising focus on personalized medicine.

Increasing focus on next generation therapeutics are likely to offer potential growth opportunities in the cell isolation market.

High cost of cell-based research is restraining the market growth.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

Global Cell Isolation Market / Cell Separation Market Dynamics

DRIVER: Increasing government funding for cell-based research

Cell isolation is mostly used to create new cell therapies and other cell-based treatments. Because of the importance of cell-based research, various government organizations around the world have increased their support for such programs. For example, in June 2024, the National Institute of Neurological Disorders and Stroke awarded the University of Buffalo scientists a five-year grant of approximately USD 2.9 million for a research project aimed at developing a new technology that could improve stem cell therapies for multiple sclerosis (MS) and other neurological diseases.

RESTRAINT: High cost of cell-based research

Cell biology researchers are conducting extensive research to develop new therapies, including gene and stem cell therapies. To obtain accurate results, the instruments, reagents, and other products used in this research must be of high quality, resulting in high cost.According to a blog published byExcedr 2024, the cost of flow cytometer systems is determined by their component and feature sets. Although some manufacturers, such as Sony Biotechnology Inc (US), are beginning to create flow cytometers for less than USD 100,000, the cost of a single instrument can still range from USD 100,000 to USD 500,000. Furthermore, the cost of conducting cell biology research is significant due to the need to follow regulatory guidelines and maintain high-quality standards. Furthermore, the success rate of cell-based research is extremely restricted, as the majority of cell therapy trials have a low success rate.

 

OPPORTUNITY: Increasing focus on next-generation therapeutics

Given the widespread success of COVID-19 vaccines, such as mRNA vaccines, the future of protein therapies has gained significant importance. Next-generation protein treatments include tailored antibodies, bi/multi-specific compounds, antibody mimics/novel scaffolds, and ligand/receptor engineers. These novel therapy approaches aim to improve therapeutic efficacy in a variety of diseases by utilizing a wide range of biologics. Promising accurate and successful treatments for diseases such HIV and dementia, antimicrobial medicines include immune-drug combos and immunological mimics such adhirons epitomize the variety in this research. Particularly in complicated diseases with limited therapeutic efficacy, next-generation protein therapeutics show great promise for transforming therapeutic methods with advances in structural biology and recombinant biologics. For example, Evaluate Pharma's (May 2023) statistics show that over 500 ADC medication candidates are now under development. Of these, more than 90% are preclinical in nature.

CHALLENGE: Technical complexities and standardization issues

The market is challenged by technological complexity and standardizing problems, therefore impeding its expansion. The complexity of cell isolation methods including magnetic isolation and flow cytometry demands specialized knowledge and sophisticated equipment, therefore restricting the advanced possibilities of small labs and hospitals. The need for specialized equipment, constant maintenance of such equipment, and the lengthy production time for novel technologies and treatments can all result in increased operational costs. As regulatory requirements are constantly changing and highly variable, standardization efforts are hampered significantly. Furthermore, the lack of standard protocols makes cell separation processes challenging in industrial and therapeutic situations where consistent quality and outcomes are required. As a result, a lack of consistency may result in disparities between research and clinical applications.

Global Cell Isolation Market / Cell Separation Market Ecosystem Analysis

The cell isolation market ecosystem consists of raw material suppliers, cell isolation product manufacturers, and end users such as pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other end users. Cell isolation products manufacturers provide consumables and instruments.

 

The consumables segment dominated the cell isolation industry in 2023

Based on products, the cell isolation market is segmented into consumables and instruments. The consumables segment is further categories into reagents, kits, media & sera, beads, and disposables. Additionally, beads are categorized into magnetic beads and fluorescent beads. The instrument segment is divided into centrifuges, cell sorters, magnetic-activated cell separator systems, and filtration systems. The consumables segment held the highest position in the market in 2023, due to the high demand for high-quality consumables for biopharmaceutical manufacturing.

The adipose tissue segment dominated the cell isolation industry in 2023

Based on the cell source, the cell isolation market is categorized into adipose tissue, bone marrow, cord blood/embryonic stem cells, and other cell sources. Adipose tissue accounted for the majority of the global market in 2023 due to its widespread use in tissue engineering products. Adipose tissue's potential for cell-based therapies and tissue engineering applications is further influenced by factors such as its ease of access, abundance of therapeutic stem cells, immunomodulatory properties, and regenerative capacity.

NORTH AMERICA Region Holds the Largest Share of the Cell Isolation Market / Cell Separation Market.

The global cell isolation market is divided into six primary regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America led the cell isolation market in 2023, followed by Europe and Asia Pacific. Several reasons contribute to this strong position, such as the well-established healthcare business, substantial investments in research and development activities, and expanded development and production of cell-based drugs.

 
 

Recent Developments of Cell Isolation Market / Cell Separation Market industry

  • In April 2024, Merck KGaA invested over USD 300 million (Euro 300 million) in a new research center at Darmstadt. This advanced research center will focus on developing solutions for antibody manufacturing, mRNA applications, and other biotechnological production needs. In September 2023, Thermo Fisher Scientific Inc. launched a next-generation platform of Gibco CTS Detachable Dynabeads, which features an active release mechanism to enable process flexibility, scalability, and cost savings while delivering high cell purity, yield, and viability, accelerating the development and commercialization of cell therapies.
  • In March 2023, Danaher Corporation partnered with the University of Pennsylvania to develop technologies for improving the consistency of clinical outcomes for patients and overcoming manufacturing bottlenecks in the delivery of next-generation engineered cell therapies.

Key Market Players

KEY PLAYERS IN THE Cell Isolation Market / Cell Separation Market INCLUDE

Want to explore hidden markets that can drive new revenue in Cell Isolation Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2024 $4.6 billion
Projected Revenue by 2029 $8.4 billion
Revenue Rate Poised to Grow at a CAGR of 12.9%
Market Driver Increasing government funding for cell-based research
Market Opportunity Increasing focus on next-generation therapeutics

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Isolation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
41
RESEARCH METHODOLOGY
47
EXECUTIVE SUMMARY
61
PREMIUM INSIGHTS
67
MARKET OVERVIEW
71
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing government funding for cell-based research
    - Surge in cases of cancer and infectious diseases
    - Rising emphasis on technological advancements and product developments
    - Growing focus on personalized medicine
    RESTRAINTS
    - Ethical and safety issues
    - High cost of cell-based research
    OPPORTUNITIES
    - Growth opportunities in emerging economies
    - Increasing focus on next-generation therapeutics
    CHALLENGES
    - Complex development process of cell therapies
    - Technical complexities and stringent regulatory requirements
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Centrifugation-based techniques
    - Magnetic cell isolation
    - Fluorescence-activated cell sorting
    - Acoustic cell isolation
    - Acoustofluidic cell isolation
    - Microfiltration
    COMPLEMENTARY TECHNOLOGIES
    - Mass cytometry
    - Cell imaging technologies
    - Artificial intelligence and machine learning
    ADJACENT TECHNOLOGIES
    - Single-cell sequencing
    - Clustered regularly interspaced short palindromic repeats and gene editing
    - 3D cell culture
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE
    AVERAGE SELLING PRICE TREND, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PATENT ANALYSIS
  • 5.8 SUPPLY CHAIN ANALYSIS
  • 5.9 ECOSYSTEM ANALYSIS
    ROLE OF RAW MATERIAL VENDORS
    ROLE OF PRODUCT PROVIDERS
    ROLE OF END USERS
    ROLE OF REGULATORY AUTHORITIES
  • 5.10 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY SCENARIO
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 KEY CONFERENCES AND EVENTS, 2024–2025
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
    BUYING CRITERIA
  • 5.14 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 382200
    EXPORT DATA FOR HS CODE 382200
  • 5.15 INVESTMENT AND FUNDING SCENARIO
  • 5.16 IMPACT OF GENERATIVE AI ON CELL ISOLATION MARKET
CELL ISOLATION MARKET, BY PRODUCT
109
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    REAGENTS, KITS, MEDIA, AND SERA
    - Surge in product launches and repetitive purchases to boost segment growth
    BEADS
    - Magnetic beads
    - Fluorescent beads
    DISPOSABLES
    - Growing government investments in research to aid market growth
  • 6.3 INSTRUMENTS
    CENTRIFUGES
    - Growing use in pharma-biotech industry to boost market
    CELL SORTERS
    - Rise in cell-based research initiatives to augment growth
    MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
    - Booming use in research for T-cell and stem cell isolation to drive market
    FILTRATION SYSTEMS
    - Rising need to ensure Good Manufacturing Practice standards and regulations to boost market
CELL ISOLATION MARKET, BY CELL TYPE
151
  • 7.1 INTRODUCTION
  • 7.2 HUMAN CELLS
    DIFFERENTIATED CELLS
    - Increasing use in disease modeling, regenerative medicine, and gene therapy to fuel growth
    STEM CELLS
    - Rise in grants and funding for stem cell research to drive market
  • 7.3 ANIMAL CELLS
    GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH
CELL ISOLATION MARKET, BY CELL SOURCE
167
  • 8.1 INTRODUCTION
  • 8.2 ADIPOSE TISSUE
    INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET
  • 8.3 BONE MARROW
    GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH
  • 8.4 CORD BLOOD/EMBRYONIC STEM CELLS
    HIGH THERAPEUTIC POTENCY TO SUPPORT MARKET GROWTH
  • 8.5 OTHER CELL SOURCES
CELL ISOLATION MARKET, BY TECHNIQUE
182
  • 9.1 INTRODUCTION
  • 9.2 CENTRIFUGATION-BASED CELL ISOLATION
    RISE IN USE BY BIOTECH AND BIOPHARMACEUTICAL COMPANIES TO FUEL MARKET
  • 9.3 SURFACE MARKER-BASED CELL ISOLATION
    INCREASING ADOPTION OF MAGNETIC-ACTIVATED CELL SORTING TO PROPEL MARKET
  • 9.4 FILTRATION-BASED CELL ISOLATION
    NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET
CELL ISOLATION MARKET, BY APPLICATION
195
  • 10.1 INTRODUCTION
  • 10.2 BIOMOLECULE ISOLATION
    INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET
  • 10.3 CANCER RESEARCH
    GROWING INCLINATION TOWARD DEVELOPING AND MANUFACTURING CANCER TREATMENTS TO DRIVE MARKET
  • 10.4 STEM CELL RESEARCH
    RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH
  • 10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
    GROWING INITIATIVES FOR RESEARCH IN REGENERATIVE MEDICINE TO SUPPORT MARKET
  • 10.6 IN VITRO DIAGNOSTICS
    NEED FOR ACCURACY TO IDENTIFY CELL TYPE TO PROPEL MARKET
  • 10.7 OTHER APPLICATIONS
CELL ISOLATION MARKET, BY END USER
218
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT
  • 11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    INCREASING NUMBER OF HEALTHCARE FACILITIES IN EMERGING ECONOMIES TO DRIVE MARKET
  • 11.5 OTHER END USERS
CELL ISOLATION MARKET, BY REGION
234
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - Rising prevalence of cancer to drive market
    CANADA
    - Increased government funding for stem cell and vaccine research to propel market
  • 12.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising interest in biotechnology drugs and applications to aid market growth
    UK
    - Increasing prevalence of infectious diseases to drive market
    FRANCE
    - Surge in investments in cell biology research activities to drive market
    ITALY
    - Rising number of cell biology seminars and conferences to drive market
    SPAIN
    - Increasing funding from private and public organizations to aid growth
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - Increasing investments in research and technological advancements to boost market
    JAPAN
    - Dominant geriatric population to aid market growth
    INDIA
    - Growing penetration of healthcare insurance services to propel market
    AUSTRALIA
    - Growing emphasis on personalized medicine, biopharmaceuticals, and advanced therapies to fuel market
    SOUTH KOREA
    - Rising need for therapeutics to support market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Need to improve public access to modern healthcare facilities to drive market
    MEXICO
    - Favorable trade agreements to support market
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    MIDDLE EAST: RECESSION IMPACT
    GCC
    - Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 12.7 AFRICA
    INCREASING PATIENT POPULATION WITH CANCER TO PROPEL MARKET
    AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
360
  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET
  • 13.3 REVENUE ANALYSIS, 2021–2023
  • 13.4 MARKET SHARE ANALYSIS, 2023
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Type footprint
    - Cell type footprint
    - End user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
383
  • 14.1 KEY PLAYERS
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BD
    - Business overview
    - Products offered
    - Recent developments
    SARTORIUS AG
    - Business overview
    - Products offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    QIAGEN
    - Business overview
    - Products offered
    - Recent developments
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products offered
    REVVITY
    - Business overview
    - Products offered
    - Recent developments
    CORNING INCORPORATED
    - Business overview
    - Products offered
    LONZA
    - Business overview
    - Products offered
    - Recent developments
    BIO-TECHNE
    - Business overview
    - Products offered
    - Recent developments
    TERUMO CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    MILTENYI BIOTEC
    - Business overview
    - Products offered
    TAKARA BIO INC.
    - Business overview
    - Products offered
    - Recent developments
    GENSCRIPT
    - Business overview
    - Products offered
    - Recent developments
    STANDARD BIOTOOLS
    - Business overview
    - Products offered
    ALFA LAVAL
    - Business overview
    - Products offered
    - Recent developments
  • 14.2 OTHER PLAYERS
    PROMEGA CORPORATION
    CELL SIGNALING TECHNOLOGY, INC.
    MICAREO INC.
    APPLIED CELLS INC.
    STEMCELL TECHNOLOGIES
    CREATIVE BIOARRAY
    PROTEINTECH GROUP, INC.
    MAGBIO GENOMICS, INC.
    AKADEUM LIFE SCIENCES
    PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
    INVENT BIOTECHNOLOGIES, INC.
APPENDIX
466
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 CELL ISOLATION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 4 NATIONAL INSTITUTES OF HEALTH FUNDING FOR CELL-BASED RESEARCH, 2019–2025 (USD MILLION)
  • TABLE 5 CANCER INCIDENCE WORLDWIDE, 2020 VS. 2040
  • TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2022
  • TABLE 7 INVESTMENT ROUNDS IN ASIA PACIFIC BIOTECH COMPANIES, 2023
  • TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2023 (USD)
  • TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD)
  • TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
  • TABLE 11 CELL ISOLATION MARKET: ROLE OF RAW MATERIAL VENDORS IN ECOSYSTEM
  • TABLE 12 CELL ISOLATION MARKET: ROLE OF PRODUCT PROVIDERS IN ECOSYSTEM
  • TABLE 13 CELL ISOLATION MARKET: ROLE OF END USERS IN ECOSYSTEM
  • TABLE 14 CELL ISOLATION MARKET: ROLE OF REGULATORY AUTHORITIES IN ECOSYSTEM
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REGULATORY GUIDELINES
  • TABLE 20 IMPACT OF PORTER’S FIVE FORCES
  • TABLE 21 KEY CONFERENCES AND EVENTS, 2024–2025
  • TABLE 22 BUYING CRITERIA, BY END USER
  • TABLE 23 IMPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (USD THOUSAND)
  • TABLE 24 IMPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (TONS)
  • TABLE 25 EXPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (USD THOUSAND)
  • TABLE 26 EXPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019–2023 (TONS)
  • TABLE 27 CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 28 CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 35 CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 36 CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 37 NORTH AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 EUROPE: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 LATIN AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 MIDDLE EAST: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 CELL ISOLATION MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 50 CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 51 CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 59 NORTH AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 EUROPE: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 LATIN AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 MIDDLE EAST: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 64 GCC COUNTRIES: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 EUROPE: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 LATIN AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 MIDDLE EAST: CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 GCC COUNTRIES: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 86 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 89 EUROPE: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 MIDDLE EAST: CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 93 GCC COUNTRIES: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 99 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 EUROPE: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 108 CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 109 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 113 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 115 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 117 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 120 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 122 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 123 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 129 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 130 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 136 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 137 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 139 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 140 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 141 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 143 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 145 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 147 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 148 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 150 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 155 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 159 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 161 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 162 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 164 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 166 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 168 CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 169 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 175 CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 EUROPE: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 LATIN AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 MIDDLE EAST: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 181 GCC COUNTRIES: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 183 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 EUROPE: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 186 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 188 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 190 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 193 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 196 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 198 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 200 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 203 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 205 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 207 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 210 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 212 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 215 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 MIDDLE EAST: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 217 GCC COUNTRIES: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 219 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 220 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 222 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 226 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 227 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 229 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 231 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 233 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 239 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 241 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 248 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 253 GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 255 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 260 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 CELL ISOLATION MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 262 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 264 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 267 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 268 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 270 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 271 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 272 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 273 US: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 274 US: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 275 US: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 276 US: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 277 US: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 278 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 279 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 280 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 281 US: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 282 US: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 283 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 284 CANADA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 285 CANADA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 286 CANADA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 287 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 289 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 290 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 291 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 292 CANADA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 293 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 295 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 296 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 297 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 298 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 299 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 300 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 301 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 302 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 303 EUROPE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 304 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 305 GERMANY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 306 GERMANY: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 307 GERMANY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 308 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 309 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 311 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 312 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 313 GERMANY: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 314 UK: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 315 UK: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 316 UK: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 UK: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 319 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 320 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 321 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 322 UK: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 323 UK: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 324 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 325 FRANCE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 326 FRANCE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 327 FRANCE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 328 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 329 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 330 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 331 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 332 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 333 FRANCE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 334 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 335 ITALY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 336 ITALY: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 337 ITALY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 338 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 339 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 341 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 342 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 343 ITALY: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 344 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 345 SPAIN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 346 SPAIN: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 347 SPAIN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 349 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 350 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 351 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 352 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 353 SPAIN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 354 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 355 REST OF EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 356 REST OF EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 357 REST OF EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 358 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 359 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 360 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 361 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 362 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 363 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 364 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 365 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 369 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 371 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 372 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 373 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 375 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 376 CHINA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 CHINA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 378 CHINA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 379 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 380 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 381 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 382 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 383 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 384 CHINA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 385 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 386 JAPAN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 387 JAPAN: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 388 JAPAN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 389 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 390 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 391 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 392 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 393 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 394 JAPAN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 395 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 396 INDIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 397 INDIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 398 INDIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 400 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, .2022–2029 (USD MILLION)
  • TABLE 402 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 403 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 404 INDIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 405 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 406 AUSTRALIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 AUSTRALIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 408 AUSTRALIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 412 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 413 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 414 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 415 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 416 SOUTH KOREA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 SOUTH KOREA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 418 SOUTH KOREA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 419 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 420 SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 421 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 422 SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 423 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 424 SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 425 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 426 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 427 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 428 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 430 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 432 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 433 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 434 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 435 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 436 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 437 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 438 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 439 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 441 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 443 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 444 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 445 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 446 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 447 BRAZIL: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 448 BRAZIL: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 449 BRAZIL: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 451 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 452 BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 453 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 454 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 455 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 456 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 457 MEXICO: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 458 MEXICO: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 459 MEXICO: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 460 MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 461 MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 462 MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 463 MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 464 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 465 MEXICO: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 466 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 467 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 468 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 469 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 470 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 472 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 473 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 474 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 475 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 476 MIDDLE EAST: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 477 MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 478 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 479 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 480 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 481 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 482 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 483 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 484 MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 485 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 486 MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 487 GCC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 488 GCC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 489 GCC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 490 GCC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 491 GCC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 492 GCC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 GCC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 GCC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 495 GCC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 496 GCC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 497 GCC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 498 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 499 SAUDI ARABIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 SAUDI ARABIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 501 SAUDI ARABIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 502 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 503 SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 505 SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 506 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 507 SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 508 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 509 UAE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 UAE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 UAE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 513 UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 515 UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 516 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 517 UAE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 518 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 519 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 522 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 523 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 525 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 526 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 527 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 528 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 529 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 531 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 534 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 535 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 536 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 537 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 538 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 539 AFRICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 540 AFRICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 AFRICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
  • TABLE 543 AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
  • TABLE 545 AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
  • TABLE 546 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 547 AFRICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 548 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 549 CELL ISOLATION MARKET: DEGREE OF COMPETITION
  • TABLE 550 CELL ISOLATION MARKET: REGION FOOTPRINT
  • TABLE 551 CELL ISOLATION MARKET: PRODUCT FOOTPRINT
  • TABLE 552 CELL ISOLATION MARKET: CELL TYPE FOOTPRINT
  • TABLE 553 CELL ISOLATION MARKET: END USER FOOTPRINT
  • TABLE 554 CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 555 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 556 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 557 CELL ISOLATION MARKET: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 558 CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 559 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 560 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 561 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 562 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 563 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 564 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 565 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 566 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 567 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 568 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 569 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 570 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 571 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 572 BD: COMPANY OVERVIEW
  • TABLE 573 BD: PRODUCTS OFFERED
  • TABLE 574 BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 575 BD: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 576 BD: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 577 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 578 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 579 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 580 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 581 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 582 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 583 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 584 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 585 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 586 QIAGEN: COMPANY OVERVIEW
  • TABLE 587 QIAGEN: PRODUCTS OFFERED
  • TABLE 588 QIAGEN: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 589 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 590 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
  • TABLE 591 REVVITY: COMPANY OVERVIEW
  • TABLE 592 REVVITY: PRODUCTS OFFERED
  • TABLE 593 REVVITY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 594 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 595 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 596 LONZA: COMPANY OVERVIEW
  • TABLE 597 LONZA: PRODUCTS OFFERED
  • TABLE 598 LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 599 LONZA: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 600 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 601 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 602 BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 603 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 604 TERUMO CORPORATION: COMPANY OVERVIEW
  • TABLE 605 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 606 TERUMO CORPORATION: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 607 MILTENYI BIOTEC: COMPANY OVERVIEW
  • TABLE 608 MILTENYI BIOTEC: PRODUCTS OFFERED
  • TABLE 609 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 610 TAKARA BIO INC.: PRODUCTS OFFERED
  • TABLE 611 TAKARA BIO INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 612 GENSCRIPT: COMPANY OVERVIEW
  • TABLE 613 GENSCRIPT: PRODUCTS OFFERED
  • TABLE 614 GENSCRIPT: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 615 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • TABLE 616 STANDARD BIOTOOLS: PRODUCTS OFFERED
  • TABLE 617 ALFA LAVAL: COMPANY OVERVIEW
  • TABLE 618 ALFA LAVAL: PRODUCTS OFFERED
  • TABLE 619 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 620 ALFA LAVAL: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 621 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 622 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 623 MICAREO INC.: COMPANY OVERVIEW
  • TABLE 624 APPLIED CELLS INC.: COMPANY OVERVIEW
  • TABLE 625 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 626 CREATIVE BIOARRAY: COMPANY OVERVIEW
  • TABLE 627 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
  • TABLE 628 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW
  • TABLE 629 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
  • TABLE 630 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW
  • TABLE 631 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2023
  • FIGURE 7 INSIGHTS FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 CELL ISOLATION MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION
  • FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET
  • FIGURE 18 INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH AND GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
  • FIGURE 19 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CELL ISOLATION MARKET IN 2023
  • FIGURE 20 BIOMOLECULE ISOLATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2023
  • FIGURE 22 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 23 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 GLOBAL HIV EPIDEMIC, 2022
  • FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE, 2021–2023 (USD)
  • FIGURE 27 VALUE CHAIN ANALYSIS
  • FIGURE 28 PATENT ANALYSIS, 2014–2024
  • FIGURE 29 SUPPLY CHAIN ANALYSIS
  • FIGURE 30 ECOSYSTEM ANALYSIS
  • FIGURE 31 PORTER’S FIVE FORCES
  • FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 33 BUYING CRITERIA, BY END USER
  • FIGURE 34 FLUORESCENCE-ACTIVATED CELL SORTERS MARKET, 2022–2029 (UNITS)
  • FIGURE 35 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF TOP 4 PLAYERS, 2021–2023 (USD MILLION)
  • FIGURE 38 MARKET SHARE ANALYSIS, 2023
  • FIGURE 39 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 CELL ISOLATION MARKET: COMPANY FOOTPRINT
  • FIGURE 41 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 COMPANY VALUATION
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 CELL ISOLATION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
  • FIGURE 55 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 56 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 57 BIO-TECHNE: COMPANY SNAPSHOT (2023)
  • FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023)
  • FIGURE 61 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
  • FIGURE 62 ALFA LAVAL: COMPANY SNAPSHOT (2023)

This research study includes significant use of secondary sources, directories, and databases to discover and collect valuable information for analyzing the global cell isolation market. In-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative data and assess the market's growth prospects. The global market size determined from secondary research was then triangulated with primary research inputs to calculate the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell isolation market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Center for Biotechnology Information (NCBI), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), and American Filtration and Separations Society (AFS), Food and Drug Administration (FDA), American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT),  American Society for Gene and Cell Therapy (ASGCT), Pharmaceutical Research and Manufacturers of America (PhRMA), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Alliance for Regenerative Medicine (ARM), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell isolation market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, CROs, and CMOs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were done in five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. About 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This data was gathered using questionnaires, e-mails, online surveys, in-person interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Cell Isolation Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell isolation market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell isolation business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cell Isolation Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Cell Isolation Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell isolation/cell separation is the process used for separation of an individual cell type from heterogeneous cell populations without contamination from another cell type. Cell isolation instruments and consuambles are widely used for various application from biological research to production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Stakeholders

  • Cell Isolation Product Manufacturers
  • Cell Biology Associations
  • Research & Consulting Firms
  • Distributors of Cell Isolation Products
  • Contract Manufacturers of Global Cell Isolation Products
  • Biotechnology, Biopharmaceutical, and Pharmaceutical Companies
  • Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, Cell Banks, and Outpatient Clinics)
  • Research Institutes and Clinical Research Organizations (CROs)
  • Venture Capitalists
  • Insurance Providers
  • Government Bodies

Report Objectives

  • To define, describe, and forecast the global cell isolation market by product, cell type, cell source, technique, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to their individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to six major regions:
  • North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
  • To profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches, agreements, partnerships, collaborations, acquisitions, and expansions in the cell isolation market
  • To benchmark players within the cell isolation market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Geographical Analysis

  • A further breakdown of the Rest of Europe  cell isolation market into countries
  • A further breakdown of the Rest of Asia Pacific cell isolation market into countries
  • A further breakdown of the Rest of Latin American cell isolation market into countries
  • A further breakdown of the Rest of Middle East cell isolation market into countries

Previous Versions of this Report

Cell Isolation Market / Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) & Region - Global Forecasts to 2025

Report Code BT 2757
Published in May, 2023, By MarketsandMarkets™

Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025

Report Code BT 2757
Published in Dec, 2020, By MarketsandMarkets™

Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024

Report Code BT 2757
Published in Feb, 2019, By MarketsandMarkets™

Cell Isolation/Cell Separation Market by Product (Reagents, Media, Serum, Beads, Centrifuge), Cell Type (Human, Stem, Animal), Technique (Surface marker, Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) - Global Forecast to 2021

Report Code BT 2757
Published in Nov, 2016, By MarketsandMarkets™

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Serum, Bead, Centrifuge), Cell Type (Human, Stem Cell, Animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & End user (Hospital, Biotechnology) - Forecast to 2020

Report Code BT 2757
Published in Dec, 2015, By MarketsandMarkets™

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

Report Code BT 2757
Published in Sep, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cell Isolation Market

DMCA.com Protection Status